Increasing evidence reveals that cardiac remodelling at the infarct border zone (IBZ) induced by MI plays a critical role in the occurrence of ventricular arrhythmias. 3, 4 Cardiac remodelling is a progressive process, which starts immediately after acute MI, evolves in the chronic phase of heart failure and finally develops into myocardial hypertrophy, interstitial fibrosis and gap junction remodelling in tissue architecture. 5 It is closely associated with changes in ventricular size, shape and function after MI. 5, 6 Previous studies have indicated that abnormal conduction exists in the IBZ, constituting the main reason for ventricular tachyarrhythmia (VT) occurrence in MI rats. 3, 4 IBZ remodelling can be considered a primary target for the prevention of ventricular arrhythmias.
7,8
Traditional Chinese medicine has been applied in the treatment of MI for thousands of years. Danqi soft capsule (DQ) is prepared from a basic formula of two Chinese herbs, including Salvia miltiorrhiza and Panax notoginseng. The combination of S miltiorrhiza and P notoginseng is one of the most widely prescribed formulas, with a remarkable protective effect on cardio-cerebrovascular diseases. [9] [10] [11] [12] The major effective ingredients of S Bunge and P notoginseng are salvianolic acids and Panax notoginseng saponins (PNS) respectively. 13, 14 Salvianolic acids prevent cardiac remodelling, including fibrosis and hypertrophy. 15 Meanwhile, PNS show cardioprotective and antifibrotic effects. 16, 17 Therefore, this study aimed to assess whether DQ prevents IBZ remodelling and decreases VT occurrence after MI.
| ME THODS

| Ethics statement
All animal procedures were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and the National Standard of the People's Republic of China for Laboratory animal Guidelines for ethical review of animal welfare.
| DQ preparation and quality control
The DQ extraction procedure and ultra-high performance liquid chromatography (UPLC) are described in the supplementary file.
| Animal model of myocardial infarction and drug administration
The MI model was carried out as our previously described. 18 Male Sprague-Dawley rats (with the weight of 250-280 g, SPF,
Guangdong Medical Experimental Animal Center) were anaesthetized. With the heart exposed by a 1.2 cm lateral thoracotomy, the left coronary artery was permanently ligated 2 mm below the tip of the left auricle with 6-0 nylon silk. 19 Other rats were gavaged with an equivalent volume of water. After 4 weeks of treatment, the rats in each group underwent echocardiographic and electrophysiological examinations as described below. Following these procedures, rats were killed and their hearts and blood removed for weighing and other assessments, as also described below.
| Echocardiogram
All rats were lightly anaesthetized with 2% sevoflurane. Transthoracic echocardiography was performed using a 21-MHz phased-array probe (Vevo 2100, VisualSonics Inc, Canada). Echocardiography was performed in the parasternal short axis B-and M-modes at the papillary muscle level to obtain left ventricular (LV) wall thickness and ejection fraction (EF), and in the parasternal long-axis view to measure LV end-systolic and end-diastolic volumes (LVESV and LVEDV).
Each echocardiographic variable was determined in at least four separate LV images acquired from the same heart. The observer was unaware of grouping and treatment.
| Programmed electrical stimulation (PES)
Programmed electrical stimulation (PES) in this study was performed essentially as described by Nguyen T 20 and Nguyen DT. tachyarrhythmias induced during the 20 paced beats at a basic cycle length of 100 ms. If the heart stopped before PES, an arrhythmia score of 8 was assigned.
| Histological analysis
Several sections of each heart (5-µm thick) were prepared, and stained with haematoxylin and eosin for histopathology. Masson's trichrome staining was performed as previously described. 21 Images were digitized using a digital camera (DP 72, Olympus) under a BX53 microscope (Olympus, Tokyo, Japan). Images were quantified by the CellSens Dimension 1.16 software (Olympus, Tokyo, Japan). The infarct area was expressed as a percentage of the fibrotic scar circumference to the total circumference; the fibrotic area was expressed as a percentage of red-positive stained area to total tissue area in the IBZ, which was defined a 3-mm zone adjacent to the infarcted area 22 using the software.
| Immunohistochemical assay
Immunohistochemical staining was performed as described previously. 23 Heart sections were stained with anti-connexin (Cx) 43 
| Quantitative real-time polymerase chain reaction
After extraction of total ribonucleic acid (RNA) from the mouse hearts using the TRIzol reagent (Invitrogen Life Technologies, USA), RNA was reverse transcribed to produce complementary DNAs (cDNAs) using the Prime Script RT reagent kit (TaKaRa, Japan). cDNA 
| Western blot
Protein concentration was determined using a BCA Protein Assay Kit 
| Enzyme-linked immunosorbent assay
Blood was taken from the abdominal aorta. The serum was separated by centrifugation and immediately stored at −80°C until further analysis. The serum levels of brain natriuretic peptide (BNP), monocyte chemoattractant protein (MCP)-1 and TGF-β1 were determined by ELISA using commercially available kits (RD, RD Systems, Minneapolis, USA), according to the manufacturer's instructions.
Absorbance was measured at 450 nm with background reading at 570 nm on a microplate reader. The concentration of each sample was calculated according to the standard curve. All concentrations were expressed in pg/mL.
| Data analysis and statistics
Data are mean ± standard deviation. All differences were normally distributed variables except arrhythmia scores and were examined by one-way anova; post hoc analyses were performed by Bonferroni correction for multiple comparison. Arrhythmia scores were examined by Kruskal-Wallis anova, with post hoc Dunn's test. The SPSS statistical software (SPSS, IL) was used for statistical analyses, and P < 0.05 indicated statistical significance. EF in MI rats decreased from 54.1 ± 3.7% at baseline to 29.5 ± 3.1% compared with the Sham group (P < 0.01, Figure 1B ). Left ventricle fraction shortening in MI rats decreased from 34.4 ± 3.6% to 15.1 ± 1.3% compared with the Sham group (P < 0.05, Figure 1C ).
| RE SULTS
| DQ improves cardiac function after MI
However, rats administered DQ at low, middle and high doses, respectively, showed significantly increased EF (P < 0.05, Figure 1B) and FS (P < 0.05, Figure 1C ) compared with the MI group. Both diastolic LV internal dimension (LVIDd, P < 0.01, Figure 1D ) and end-systolic LV internal dimension (LVIDs, P < 0.01, Figure 1E ) were elevated in the MI group, but decreased after DQ treatment (both P < 0.05). Arrhythmia scores in the DQ-M and DQ-L groups were also lower than those of the MI group (P < 0.05, Figure 2C ). The conduction velocity was lower in the MI group than in the Sham group (P < 0.01, Supporting Information). This decrease was reversed after administering DQ, with a recovery of conduction velocity observed in DQ-treated groups.
| DQ inhibits susceptibility to VT in rats with MI
These results suggested that DQ could reduce susceptibility to PES VT and increase conduction velocity after MI.
| DQ inhibits cardiac fibrosis in IBZ
Histology confirmed large infarcted areas ( Figure 3A) , with an infarct percentage of 38% ± 3.6% in MI rats ( Figure 3B) ; the fibrotic tissue within the IBZ accounted for 42.3 ± 4.5% of total area ( Figure 3C ). DQ effectively decreased the total infarct areas (P < 0.05, Figure 3B ) and fibrotic areas in the IBZ (P < 0.05, Figure 3C ). To quantify the impact of DQ on collagen amounts, type I and III collagen were detected by Western blot. MI resulted in significantly increased type I and III collagen deposition ( Figure 3D and Figure 3E ). DQ treatment markedly reduced type I (P < 0.05 in the DQ-L group, and P < 0.01 in the DQ-M and DQ-H groups; Figure 3D ) and III (P < 0.05 in the DQ-L group, and P < 0.01 in the DQ -M and DQ -H groups; Figure 3E ) collagen deposition.
| DQ reverses Cx43 expression and distribution in the IBZ
Immunohistochemistry showed the Cx43 staining in LV sections of sham-operated rats, predominantly localized to the myocyte-myocyte junction corresponding to intercalated discs. Cx43 in the MI model group was clearly decreased and had a disordered and uneven distribution ( Figure 4A ). The immunohistochemical levels of Cx43 were significantly reduced in the IBZ in MI rats compared with Sham animals (P < 0.05, Figure 4B ). Meanwhile, Western blot showed that Cx43 protein levels in the IBZ were markedly decreased in MI rats compared with Sham animals (P < 0.01, Figure 4C ). The expression and distribution of Cx43 in the DQ group were significantly reversed compared with the MI group (P < 0.05 in the DQ-L and DQ-M groups; P < 0.01 in the DQ-H group).
| DQ inhibits myocyte hypertrophy in the IBZ
Five weeks post-MI, rats developed significantly increased heart weight (HW)/bodyweight (BW) ratios (P < 0.05, Figure 5A ) and LV weight (LVW)/HW ratios (P < 0.05, Figure 5B) ; meanwhile, DQ inhibited the above indexes (P < 0.05 in the DQ-M and DQ-L groups).
Haematoxylin and eosin staining was used to assess myocyte morphology and transverse diameters ( Figure 5C ). Five weeks post-MI, animals developed a higher degree of hypertrophy with a sparser myocyte distribution and increasing myocyte area; DQ treatment inhibited MI-induced myocyte hypertrophy and showed a denser myocyte distribution and reduced myocyte area ( Figure 5D ). Results of the qRT-PCR also showed that the enhanced expression levels of the hypertrophic markers natriuretic peptide ANP were significantly decreased in DQ rats in comparison to MI rats ( Figure 5E ). Collectively, our results suggest that DQ inhibited myocyte hypertrophy in IBZ.
| DQ inhibits myofibroblast differentiation in MI rats and TGF-β1/Smad3 pathway
In MI rats, α-SMA was markedly increased in the IBZ compared with
Sham rats (P < 0.01, Figure 6A ). DQ treatment resulted in reduced F I G U R E 2 Effects of DQ on PESinduced ventricular tachyarrhythmia. A, Various ventricular arrhythmias induced by programmed electrical stimulation in rats. a, Eight basic stimuli (S1) at cycle lengths of 120 ms and three extra-stimuli (S2, S3 and S4) induced no ventricular tachycardia (VT). b, Eight basic stimuli (S1) and two extra-stimuli (S2 and S3) induced non-sustained VT. c, Eight basic stimuli (S1) and one extra-stimulus (S2) induced sustained VT. B, Inducibility of VT 5 weeks after infarction. C, Scores of inducible VT. *P < 0.05 vs Sham group, # P < 0.05 vs MI group, n = 15 rats/group protein expression of α-SMA compared with MI rats (P < 0.05 in the DQ-L and DQ-M groups, and P < 0.01 in the DQ -H group; Figure 6A ).
TGF-β1 levels were markedly increased in the MI group compared with the Sham group (P < 0.01, Figure 6B ). DQ attenuated the TGF-β1 level increase after MI (P < 0.05 in the DQ-L group, and P < 0.01 in the DQ-M and DQ-H groups; Figure 6B ). Smad3 amounts showed no difference among the five groups (P > 0.05, Figure 6C ). But DQ decreased Smad3 phosphorylation (p-Smad3) after MI (P < 0.05 in the DQ-L group, and P < 0.01 in the DQ-M and DQ-H groups; Figure 6D ).
| DQ decreases the serum level of BNP, MCP-1 and TGF-β1
As shown in Figure 7 , serum levels of BNP, MCP-1 and TGF-β1
were all increased in the MI group compared with Sham animals (P < 0.01). After 4 weeks of DQ treatment the increased levels of BNP, MCP-1 and TGF-β1 were reversed in the three different dose groups compared with the MI group (BNP, P < 0.01, Figure 7A ; MCP-1, P < 0.05, Figure 7B ; TGF-β1, P < 0.01, Figure 7C ).
F I G U R E 3 Effect of DQ on interstitial fibrosis. A, Representative images
showing ventricular myocardial fibrosis (Masson stain, which stains fibrosis blue and viable muscle red). B, Statistical results of percentage of infarcted areas (n = 5 rats/group). C, Statistical results of fibrosis areas in the infarct border zone. DQ reduced fibrosis-positive area (n = 5 rats/group). D, DQ reduced the protein levels of collagen Ⅰ as assessed by Western blot (n = 5 rats/group). E, DQ reduced the protein levels of collagen III as assessed by Western blot (n = 5 rats/group). *P < 0.05, **P < 0.01 vs Sham group, # P < 0.05, ## P < 0.01 vs MI group
| D ISCUSS I ON
The Chinese herb combination S miltiorrhiza and P notoginseng is one of the most widely prescribed formulas, and has remarkable protective effects on heart failure 10 and coronary heart disease. 24, 25 The present study demonstrated the considerable long-term cardiac Interstitial fibrosis is the main pathological change in post-MI structural remodelling in the IBZ. 34 Excessive collagen, generated by activated fibroblasts, increases the stiffness of the myocardial wall and is linked to cardiac remodelling, thereby impeding normal electrical conduction function. 35 Diffuse interstitial fibrosis is an independent predictor of the likelihood of developing electrophysiological disturbances resulting in cardiac arrhythmia. 36 Therefore, inhibiting or reversing fibrosis is an established target of many interventions for treating ventricular arrhythmias. 37 These interventions may lead to a partial recovery of conduction function in the IBZ by decreasing fibrosis, thereby reducing susceptibility to VT. 4 In the present 43 In the present study, DQ reduced α-SMA and type I and III collagen expression levels in MI rats, indicating that it could inhibit cardiac fibroblast-myofibroblast transition in vivo. TGF-β1 is a major mediator of myofibroblast formation after MI. 44 TGF-β1
and p-Smad3 were up-regulated in the MI group and reversed after treatment with DQ for 4 weeks. The serum levels of BNP, MCP-1 and TGF-β1 were also decreased in the DQ group compared with the MI group. These results indicate that DQ inhibits myofibroblast transition by inhibiting the TGF-β1/Smad3 pathway or some related factors. DQ decreased susceptibility to VT by inhibiting IBZ fibrosis through its inhibitory effect on myofibroblast transition.
Traditionally, interstitial fibrosis is considered to alter cardiac electrophysiology by mechanically separating myocytes and creating barriers to propagation of the electrical impulse. There is increasing evidence that fibroblasts may also actively contribute to cardiac electrophysiology and arrhythmogenesis through direct electrical coupling. 45 Gap junction abnormality is as a key molecular feature of the arrhythmogenic substrate. 46 Theoretical modelling and studies of connexin expression in diseased human and experimental animal hearts suggest that altered gap junction protein expression or function may underlie the high incidence of arrhythmias associated with F I G U R E 5 Effect of DQ on myocyte hypertrophy. A, Quantitative analysis of HW/BW (n = 10 rats/group). B, Quantitative analysis of LVW/BW (n = 10 rats/group). C, Haematoxylin and eosin staining of representative cross-sections of cardiac myocytes. D, Quantitative analysis of myocyte cross-sectional areas (n = 5 rats/group). E, ANP mRNA qRT-PCR analysis (n = 5 rats/group). *P < 0.05, **P < 0.01 vs Sham group, # P < 0.05, ## P < 0.01 vs MI group many forms of heart disease, including hypertrophic, ischaemic and dilated cardiomyopathy. [47] [48] [49] [50] Cx43 is the most abundant and arguably the most important physiologically relevant protein in the working myocardium of the ventricle. It was reported that cardiac-restricted knockout of Cx43 causes a conduction disorder and sudden cardiac death from spontaneous ventricular arrhythmias in mice. 46 Low levels of Cx43 in the gap junction have been reported in the hypertrophied and ischaemic human heart, and depleting gap junction plaques containing Cx43 slow ventricular conduction velocity, leading to arrhythmia and sudden cardiac death. 48, 49, 51 In the present study, MI resulted in decreased Cx43 expression in the IBZ, corroborating previous reports on Cx43 level changes in experimental MI models. 52, 53 Further, F I G U R E 6 Effect of DQ on fibroblasts differentiation to myofibroblasts. A, DQ reduced the protein levels of α-SMA as assessed by Western blot (n = 5 rats/ group). B, DQ reduced the protein levels of TGF-β1 as assessed by Western blot (n = 5 rats/group). C, DQ had no effect on the protein levels of Smad3 as assessed by Western blot (n = 5 rats/group). D, DQ reduced the protein levels of p-Smad3 as assessed by Western blot (n = 5 rats/ group). *P < 0.05, **P < 0.01 vs Sham group, # P < 0.05, ## P < 0.01 vs MI group F I G U R E 7 Effects of DQ on serum levels of BNP, MCP-1 and TGF-β1. A, Serum levels of BNP, decreased by DQ (n = 10 rats/group). B, Serum levels of MCP-1, decreased by DQ (n = 10 rats/ group). C, Serum levels of TGF-β1, decreased by DQ (n = 10 rats/group). *P < 0.05, **P < 0.01 vs Sham group, # P < 0.05, ## P < 0.01 vs MI group DQ effectively increased Cx43 levels in the IBZ 5 weeks after MI, thereby reducing vulnerability/susceptibility to VT, by up-regulating 
| CON CLUS ION
In summary, the present study mainly demonstrated that DQ re- 
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